Form 4 for RVMD Revolution Medicines, Inc.

Accepted 2024-12-09 00:00:00 ET · period of report 2024-12-05 · accession 0001415889-24-028638 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
MI	2024-12-09	2024-12-05	RVMD	Schroeder Thilo	Dir	P - Purchase	$46.00	+1.30M	760.9K	New	+$60.00M

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2024-12-05	P	A	543,478	$46.00	2,096,612	I By Nextech Crossover I SCSP	—	—	(F1) Nextech Invest AG is the investment advisor of Nextech Crossover I SCSP ("Nextech Crossover"). The Reporting Person is a managing member of Nextech Invest AG and may therefore be deemed to be the beneficial owner of shares held by Nextech Crossover. The Reporting Person disclaims beneficial ownership of such shares, except to the extent of any pecuniary interest therein.
2	Common	Common Stock	2024-12-05	P	A	760,869	$46.00	760,869	I By Nextech VIII SCSP	—	—	(F2) Nextech Invest AG is the investment advisor of Nextech VIII SCSP ("Nextech VIII"). The Reporting Person is a managing member of Nextech Invest AG and may therefore be deemed to be the beneficial owner of shares held by Nextech VIII. The Reporting Person disclaims beneficial ownership of such shares, except to the extent of any pecuniary interest therein.